Ensysce Biosciences Ownership 2024 | Who Owns Ensysce Biosciences Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.00%

Insider Ownership

1.54%

Retail Ownership

98.45%

Institutional Holders

1.00

Ensysce Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PLANTE MORAN FINANCIAL ADVISORS, LLC	0.00%	-	20	-	-	10	Jun 30, 2024

Ensysce Biosciences's largest institutional shareholder is PLANTE MORAN FINANCIAL ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at $10.00. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PLANTE MORAN FINANCIAL ADVISORS, LLC	0.00%	-	20	-	-	10	Jun 30, 2024

The largest Ensysce Biosciences shareholder by % of total assets is PLANTE MORAN FINANCIAL ADVISORS, LLC. The company owns 20.00 shares of Ensysce Biosciences (ENSC), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PLANTE MORAN FINANCIAL ADVISORS, LLC	0.00%	-	20	-	-	10	Jun 30, 2024

As of Jun 30 2024, Ensysce Biosciences's largest institutional buyer is PLANTE MORAN FINANCIAL ADVISORS, LLC. The company purchased 0.00 stocks of ENSC, valued at $10.00.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PLANTE MORAN FINANCIAL ADVISORS, LLC	0.00%	-	20	-	-	10	Jun 30, 2024

As of Jun 30 2024, Ensysce Biosciences's biggest institutional seller is PLANTE MORAN FINANCIAL ADVISORS, LLC. The company sold 0.00 shares of ENSC, valued at $10.00.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Ensysce Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	315,828	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	119,707	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	18,289	1,989	12.20%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	18,175	-18,175	-50.00%	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,675	-	-	Jan 31, 2024

Ensysce Biosciences's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 315.83K shares, compromising 0.00% of its total assets.

Ensysce Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	1	-
31 Mar, 24	1	-50.00%
31 Dec, 23	2	100.00%
30 Sep, 23	1	-
30 Jun, 23	1	-50.00%
31 Mar, 23	2	100.00%
31 Dec, 22	1	-93.33%
30 Sep, 22	15	-11.76%
30 Jun, 22	17	6.25%
31 Mar, 22	16	-
31 Dec, 21	16	6.67%
30 Sep, 21	15	-

As of 30 Jun 24, 1 institutions are holding Ensysce Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	20	-
31 Mar, 24	20	-94.55%
31 Dec, 23	367	1735.00%
30 Sep, 23	20	-
30 Jun, 23	20	-94.55%
31 Mar, 23	367	47.98%
31 Dec, 22	248	-99.99%
30 Sep, 22	3,770,265	-3.60%
30 Jun, 22	3,911,128	-28.43%
31 Mar, 22	5,465,134	61.82%
31 Dec, 21	3,377,202	7.03%
30 Sep, 21	3,155,311	-

Ensysce Biosciences (ENSC) has 20.00 shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.00%	44177.78%
31 Mar, 24	0.00%	624.37%
31 Dec, 23	0.01%	10631.13%
30 Sep, 23	0.01%	292778.95%
30 Jun, 23	0.00%	156.61%
31 Mar, 23	0.03%	230866.67%
31 Dec, 22	0.00%	0.04%
30 Sep, 22	2.94%	31.62%
30 Jun, 22	3.05%	16.80%
31 Mar, 22	4.26%	61.47%
31 Dec, 21	2.63%	43.51%
30 Sep, 21	2.46%	-

As of 30 Jun 24, Ensysce Biosciences is held by 0.00% institutional shareholders, representing a 44177.78% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	-	-
31 Mar, 24	-	-100.00%
31 Dec, 23	1	-
30 Sep, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-
31 Dec, 22	1	-90.00%
30 Sep, 22	10	42.86%
30 Jun, 22	7	-22.22%
31 Mar, 22	9	-18.18%
31 Dec, 21	11	-26.67%
30 Sep, 21	15	-

- institutional shareholders have increased their position in ENSC stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-
31 Mar, 24	-	-
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-
31 Dec, 22	-	-
30 Sep, 22	-	-100.00%
30 Jun, 22	3	-25.00%
31 Mar, 22	4	33.33%
31 Dec, 21	3	-
30 Sep, 21	-	-

- institutional shareholders have reduced their position in ENSC stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	1	-	20	-	0.00%	44177.78%	-	-	-	-
31 Mar, 24	1	-50.00%	20	-94.55%	0.00%	624.37%	-	-100.00%	-	-
31 Dec, 23	2	100.00%	367	1735.00%	0.01%	10631.13%	1	-	-	-
30 Sep, 23	1	-	20	-	0.01%	292778.95%	-	-	-	-
30 Jun, 23	1	-50.00%	20	-94.55%	0.00%	156.61%	-	-100.00%	-	-100.00%
31 Mar, 23	2	100.00%	367	47.98%	0.03%	230866.67%	1	-	1	-
31 Dec, 22	1	-93.33%	248	-99.99%	0.00%	0.04%	1	-90.00%	-	-
30 Sep, 22	15	-11.76%	3,770,265	-3.60%	2.94%	31.62%	10	42.86%	-	-100.00%
30 Jun, 22	17	6.25%	3,911,128	-28.43%	3.05%	16.80%	7	-22.22%	3	-25.00%
31 Mar, 22	16	-	5,465,134	61.82%	4.26%	61.47%	9	-18.18%	4	33.33%
31 Dec, 21	16	6.67%	3,377,202	7.03%	2.63%	43.51%	11	-26.67%	3	-
30 Sep, 21	15	-	3,155,311	-	2.46%	-	15	-	-	-

Ensysce Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 06, 2023	GOWER BOB G	director	-	P-Purchase	Buy	90,287	$0.49	$44.09K	1,222,682
Mar 02, 2023	GOWER BOB G	director	-	P-Purchase	Buy	270,000	$0.48	$128.98K	1,132,395
Mar 02, 2023	GOWER BOB G	director	-	P-Purchase	Buy	109,300	$0.49	$53.37K	862,395
Feb 01, 2023	GOWER BOB G	director	-	P-Purchase	Buy	357,143	$1.40	$500.00K	753,095
May 27, 2022	Kirkpatrick Lynn	officer	Chief Executive Officer	P-Purchase	Buy	27,000	$0.53	$14.22K	381,851

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 06, 2023	GOWER BOB G	director	-	P-Purchase	Buy	90,287	$0.49	$44.09K	1,222,682
Mar 02, 2023	GOWER BOB G	director	-	P-Purchase	Buy	270,000	$0.48	$128.98K	1,132,395
Mar 02, 2023	GOWER BOB G	director	-	P-Purchase	Buy	109,300	$0.49	$53.37K	862,395
Feb 01, 2023	GOWER BOB G	director	-	P-Purchase	Buy	357,143	$1.40	$500.00K	753,095
May 27, 2022	Kirkpatrick Lynn	officer	Chief Executive Officer	P-Purchase	Buy	27,000	$0.53	$14.22K	381,851

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
May 04, 2022	Osman Nilab	officer	Chief Medical Officer		Sell	200,000	$1.07	$214.00K	-
Feb 15, 2022	Rauch Lee M.	director	-		Sell	20,000	$1.70	$34.00K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 06, 2023	GOWER BOB G	director	-	P-Purchase	Buy	90,287	$0.49	$44.09K	1,222,682
Mar 02, 2023	GOWER BOB G	director	-	P-Purchase	Buy	270,000	$0.48	$128.98K	1,132,395
Mar 02, 2023	GOWER BOB G	director	-	P-Purchase	Buy	109,300	$0.49	$53.37K	862,395
Feb 01, 2023	GOWER BOB G	director	-	P-Purchase	Buy	357,143	$1.40	$500.00K	753,095
Feb 01, 2023	GOWER BOB G	director	-	A-Award	Buy	714,286	$1.40	$1.00M	716,365
Jun 27, 2022	Chang William H	director		A-Award	Buy	15,000	-	-	35,000
Jun 27, 2022	Martin Steven Robert	director		A-Award	Buy	15,000	-	-	100,850
Jun 27, 2022	Rauch Lee M.	director		A-Award	Buy	15,000	-	-	35,000
Jun 27, 2022	GOWER BOB G	director		A-Award	Buy	15,000	-	-	41,585
Jun 27, 2022	GOWER BOB G	director, 10 percent owner		A-Award	Buy	15,000	$0.42	$6.38K	41,585
Jun 27, 2022	Rosebraugh Curtis	director		A-Award	Buy	20,000	-	-	35,000
Jun 27, 2022	Benton Andrew	director		A-Award	Buy	15,000	-	-	100,850
Jun 27, 2022	Levin Adam	director		A-Award	Buy	15,000	-	-	35,000
May 27, 2022	Kirkpatrick Lynn	officer	Chief Executive Officer	A-Award	Buy	200,000	-	-	2,516,939
May 27, 2022	Kirkpatrick Lynn	officer	Chief Executive Officer	P-Purchase	Buy	27,000	$0.53	$14.22K	381,851
May 04, 2022	Osman Nilab	officer	Chief Medical Officer		Sell	200,000	$1.07	$214.00K	-
Feb 24, 2022	Humphrey David Carl	officer	Chief Financial Officer	A-Award	Buy	80,000	$1.40	$112.00K	80,000
Feb 24, 2022	Birkett Kevin Geoffrey	officer	Chief Commercial Officer	A-Award	Buy	50,000	$1.40	$70.00K	50,000
Feb 24, 2022	Kirkpatrick Lynn	director, officer	Chief Executive Officer	A-Award	Buy	200,000	$1.40	$280.00K	200,000
Feb 15, 2022	Rauch Lee M.	director	-		Sell	20,000	$1.70	$34.00K	-

The last insider sell of Ensysce Biosciences's stock was made by Osman Nilab on May 04 2022, selling 200,000 shares at $1.07 per share (valued at $214.00K). The last insider buy of ENSC was made by GOWER BOB G on Mar 06 2023, buying 90,287 shares at $0.49 per share (worth $44.09K).

Ensysce Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	3	-	-
Q4 2022	2	-	-
Q2 2022	9	1	900.00%
Q1 2022	11	1	1100.00%
Q4 2021	-	-	-
Q2 2021	25	2	1250.00%
Q2 2020	-	1	-
Q1 2020	-	-	-
Q1 2018	-	6	-
Q4 2017	1	12	8.33%

3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Ensysce Biosciences's insiders, as of Q1 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	3	-	-
Q4 2022	1	-	-
Q2 2022	1	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q2 2021	-	-	-
Q2 2020	-	1	-
Q1 2020	-	-	-
Q1 2018	-	-	-
Q4 2017	1	-	-

As of Q1 2023, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Ensysce Biosciences's stocks.

Ensysce Biosciences Peer Ownership

Ticker	Company
BDRX	Biodexa Pharmaceuticals Plc
BWV	Onconetix, Inc.
KPRX	Kiora Pharmaceuticals, Inc.
PXMD	PaxMedica, Inc. Common Stock
PHIO	Phio Pharmaceuticals Corp.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
ZURA	Zura Bio Limited
CDIO	Cardio Diagnostics Holdings, Inc.
ATNF	180 Life Sciences Corp.

ENSC Ownership FAQ

Who Owns Ensysce Biosciences?

Ensysce Biosciences is owned by institutional shareholders (0.00%), insiders (1.54%), and public (98.45%). The largest institutional shareholder of Ensysce Biosciences is PLANTE MORAN FINANCIAL ADVISORS, LLC (0.00% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Ensysce Biosciences?

Ensysce Biosciences's major institutional shareholders are PLANTE MORAN FINANCIAL ADVISORS, LLC. The top five shareholders own together 0.00% of the company's share outstanding.

How many Ensysce Biosciences shareholders are there?

As of Jun 2024, there are 1 institutional shareholders of Ensysce Biosciences.

What percentage of Ensysce Biosciences is owned by PLANTE MORAN FINANCIAL ADVISORS, LLC?

PLANTE MORAN FINANCIAL ADVISORS, LLC owns 20 shares of Ensysce Biosciences, representing 0.00% of the company's total shares outstanding, valued at $10 (as of Jun 2024).